Irritable Bowel Syndrome

Top Story

Depression, anxiety levels higher in all IBS subtypes

July 18, 2017

Patients with irritable bowel syndrome, regardless of subtype, show higher levels of depression and anxiety compared with healthy controls, according to the results of a meta-analysis performed by the Brain-Gut Axis Research Group of the Korean Society of Neurogastroenterology and Motility.

Among IBS subtypes, patients with constipation-predominant IBS (IBS-C) showed the highest levels of both depression and anxiety.

Meeting News

Stress, not diet, likely source of GI problems in children with autism

July 14, 2017
Stress, not dietary intake, contributes to gastrointestinal issues in children with autism spectrum disorder, according to a presentation from the 2017 International…
Meeting News

Low FODMAP diet with prebiotic supplement improves IBS symptoms

July 11, 2017
The combination of a low FODMAP diet and a prebiotic supplement resulted in significantly greater symptom improvement in patients with irritable bowel syndrome compared…

New patent to cover treatment for IBS-C

June 29, 2017
The U.S. Patent and Trademark Office issued allowance of a patent application covering SYN-010, a modified formulation of lovastatin lactone, created by Synthetic…
More Headlines »

The Patient with Dyspepsia

No commercial support for this activity.

Helicobacter pylori is a gram-negative flagellated bacterium organism that is present in over one-half of the world’s…
More »
GI Bookshelf

Chapter 5: Dysplasia And Colorectal Cancer

From Clinical Challenges and Complications of IBD
More »
Resource Centers
Biosimilars in the US

Biosimilars in the US

Meeting News Coverage

VIDEO: Chey discusses benefits of tenapanor in IBS-C

October 20, 2016
More »